Analysis of the Efficacy and Safety of Recombinant Tissue Plasminogen Activator for Chinese Patients over 80 Years of Age with Acute Ischemic Stroke： A Pilot Study

Dear Editor,Recombinant tissue plasminogen activator（rt-PA）remains the only proven therapy for acute ischemic stroke patients who meet the selection criteria for treatment[1–3].A small number of studies have investigated the efficacy of rt-PA for elderly stroke patients in Japanese and Caucasian pop...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neuroscience bulletin 2016-04, Vol.32 (2), p.202-203
Hauptverfasser:	Yang, Jiandao, Liang, Huazheng, Song, Yanyan, Shen, Lingda, Wang, Shaoshi
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged, 80 and over Anatomy Anesthesiology Asian Continental Ancestry Group Biomedical and Life Sciences Biomedicine Brain Ischemia - complications Care and treatment Female Fibrinolytic Agents - therapeutic use Human Physiology Humans Ischemia Letter to the Editor Male Neurology Neurosciences Pain Medicine Pilot Projects Severity of Illness Index Stroke (Disease) Stroke - drug therapy Stroke - etiology Stroke patients Tissue plasminogen activator Tissue Plasminogen Activator - therapeutic use Treatment Outcome 安全性分析急性治疗疗效组织型纤溶酶原激活物缺血脑卒中重组
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Dear Editor,Recombinant tissue plasminogen activator（rt-PA）remains the only proven therapy for acute ischemic stroke patients who meet the selection criteria for treatment[1–3].A small number of studies have investigated the efficacy of rt-PA for elderly stroke patients in Japanese and Caucasian populations[4,5].According to the American Heart Association/American Stroke Association Guidelines,
ISSN:	1673-7067 1995-8218
DOI:	10.1007/s12264-016-0020-2